ClinConnect ClinConnect Logo
Search / Trial NCT03815968

Low Sodium Diet in Oligohydramnios Assigned for Conservative Management

Launched by WOLFSON MEDICAL CENTER · Jan 23, 2019

Trial Information

Current as of May 28, 2025

Unknown status

Keywords

Oligohydroamnios Low Salt Diet

ClinConnect Summary

Few studies have addressed the changes in maternal diet as affecting the composition and amount of amniotic fluid.

Some articles have shown an increase in amniotic fluid volume as a result of maternal hydration during pregnancy through intravenous fluid infusions and oral fluid intake, the increase was evident in women with amniotic fluid and women with normal amniotic fluid volume. In a mechanism similar to that of liquid hydration, a low-salt diet may lead to an increase in the volume of amniotic fluid.

The investigators would like to examine whether a low-salt diet in women with amniot...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women between 24-37 weeks of gestation, single fetus, who were diagnosed with an amniotic fluid index at the 5th percentile or below, according to the current gestational age
  • No medical indication for immediate delivery
  • Exclusion Criteria:
  • Refusal to participate in the study
  • A medical recommendation for delivery within two weeks of diagnosis
  • Fetal malformation or proof of fetal infection that known to cause oligohydramnios (eg CMV).
  • Premature rupture of membrane
  • Multiple pregnancy
  • Medical contraindication to the low-salt diet

About Wolfson Medical Center

Wolfson Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in the heart of Israel, the center is equipped with state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals. Wolfson Medical Center actively engages in a wide range of clinical studies, focusing on diverse therapeutic areas, to explore new treatment modalities and enhance existing care protocols. Committed to ethical standards and patient safety, the center fosters collaboration with global research networks to contribute to the advancement of medical science and the development of effective therapies.

Locations

H̱olon, , Israel

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials